<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;fc=20230708114047&amp;ff=20231110193728&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;fc=20230708114047&amp;ff=20231110193728&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sat, 11 Nov 2023 00:37:29 +0000</lastbuilddate>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>The evolution of transcatheter valvular interventions: current evidence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947282/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 8:ehad713. doi: 10.1093/eurheartj/ehad713. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947282/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947282</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad713>10.1093/eurheartj/ehad713</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947282</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Rasha Kaddoura</dc:creator>
<dc:creator>Mohammed Al-Hijji</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The evolution of transcatheter valvular interventions: current evidence</dc:title>
<dc:identifier>pmid:37947282</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad713</dc:identifier>
</item>
<item>
<title>Public access of automated electrical defibrillators through mosques and other places of worship-towards saving lives and reducing health inequalities</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947281/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 8:ehad705. doi: 10.1093/eurheartj/ehad705. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947281/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947281</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad705>10.1093/eurheartj/ehad705</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947281</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Mohammed Y Khanji</dc:creator>
<dc:creator>Sameen Nassar</dc:creator>
<dc:creator>Salman Waqar</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Public access of automated electrical defibrillators through mosques and other places of worship-towards saving lives and reducing health inequalities</dc:title>
<dc:identifier>pmid:37947281</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad705</dc:identifier>
</item>
<item>
<title>Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947270/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 8:ehad682. doi: 10.1093/eurheartj/ehad682. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947270/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947270</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad682>10.1093/eurheartj/ehad682</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947270</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Giuseppe Danilo Norata</dc:creator>
<dc:creator>Lale Tokgözoğlu</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering</dc:title>
<dc:identifier>pmid:37947270</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad682</dc:identifier>
</item>
<item>
<title>Reports from 2023 Great Wall International Congress of Cardiology in China</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947267/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 8:ehad737. doi: 10.1093/eurheartj/ehad737. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947267/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947267</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad737>10.1093/eurheartj/ehad737</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947267</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Feng Cao</dc:creator>
<dc:creator>Yabin Wang</dc:creator>
<dc:creator>Yongjian Wu</dc:creator>
<dc:creator>Changsheng Ma</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Reports from 2023 Great Wall International Congress of Cardiology in China</dc:title>
<dc:identifier>pmid:37947267</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad737</dc:identifier>
</item>
<item>
<title>Disturbed Sleep Supports Neutrophil Activation and Promotes Atherosclerosis and Plaque Necrosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947098/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10. doi: 10.1161/CIRCRESAHA.123.322858. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947098/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947098</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322858>10.1161/CIRCRESAHA.123.322858</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947098</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Alina K Moriarty</dc:creator>
<dc:creator>Tayab C Waseem</dc:creator>
<dc:creator>W Coles Keeter</dc:creator>
<dc:creator>Shelby D Ma</dc:creator>
<dc:creator>Robin Bai</dc:creator>
<dc:creator>Aleksandr V Ivanov</dc:creator>
<dc:creator>Cassandra L Kirk</dc:creator>
<dc:creator>Marion Mussbacher</dc:creator>
<dc:creator>Larry D Sanford</dc:creator>
<dc:creator>Elena V Galkina</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Disturbed Sleep Supports Neutrophil Activation and Promotes Atherosclerosis and Plaque Necrosis</dc:title>
<dc:identifier>pmid:37947098</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322858</dc:identifier>
</item>
<item>
<title>Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease. Epidemiological data demonstrate higher absolute risk of both atherosclerotic cardiovascular disease (CVD) and heart failure as an individual progresses from CKM stage 0 to stage 3, but optimal strategies for risk assessment need to be refined. Absolute risk assessment with the goal to match type and intensity...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 10. doi: 10.1161/CIR.0000000000001191. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease. Epidemiological data demonstrate higher absolute risk of both atherosclerotic cardiovascular disease (CVD) and heart failure as an individual progresses from CKM stage 0 to stage 3, but optimal strategies for risk assessment need to be refined. Absolute risk assessment with the goal to match type and intensity of interventions with predicted risk and expected treatment benefit remains the cornerstone of primary prevention. Given the growing number of therapies in our armamentarium that simultaneously address all 3 CKM axes, novel risk prediction equations are needed that incorporate predictors and outcomes relevant to the CKM context. This should also include social determinants of health, which are key upstream drivers of CVD, to more equitably estimate and address risk. This scientific statement summarizes the background, rationale, and clinical implications for the newly developed sex-specific, race-free risk equations: PREVENT (AHA Predicting Risk of CVD Events). The PREVENT equations enable 10- and 30-year risk estimates for total CVD (composite of atherosclerotic CVD and heart failure), include estimated glomerular filtration rate as a predictor, and adjust for competing risk of non-CVD death among adults 30 to 79 years of age. Additional models accommodate enhanced predictive utility with the addition of CKM factors when clinically indicated for measurement (urine albumin-to-creatinine ratio and hemoglobin A1c) or social determinants of health (social deprivation index) when available. Approaches to implement risk-based prevention using PREVENT across various settings are discussed.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947094</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001191>10.1161/CIR.0000000000001191</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947094</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Sadiya S Khan</dc:creator>
<dc:creator>Josef Coresh</dc:creator>
<dc:creator>Michael J Pencina</dc:creator>
<dc:creator>Chiadi E Ndumele</dc:creator>
<dc:creator>Janani Rangaswami</dc:creator>
<dc:creator>Sheryl L Chow</dc:creator>
<dc:creator>Latha P Palaniappan</dc:creator>
<dc:creator>Laurence S Sperling</dc:creator>
<dc:creator>Salim S Virani</dc:creator>
<dc:creator>Jennifer E Ho</dc:creator>
<dc:creator>Ian J Neeland</dc:creator>
<dc:creator>Katherine R Tuttle</dc:creator>
<dc:creator>Radhika Rajgopal Singh</dc:creator>
<dc:creator>Mitchell S V Elkind</dc:creator>
<dc:creator>Donald M Lloyd-Jones</dc:creator>
<dc:creator>American Heart Association</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37947094</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001191</dc:identifier>
</item>
<item>
<title>Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37947085/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>Background: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the AHA Predicting Risk of CVD EVENTs (PREVENT) equations among US adults aged 30-79 years without known CVD. Methods: The derivation sample included individual-level participant data from 25 datasets (N=3,281,919) between 1992-2017. The primary outcome was CVD...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 10. doi: 10.1161/CIRCULATIONAHA.123.067626. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Background:</b> Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the AHA Predicting Risk of CVD EVENTs (PREVENT) equations among US adults aged 30-79 years without known CVD. <b>Methods:</b> The derivation sample included individual-level participant data from 25 datasets (N=3,281,919) between 1992-2017. The primary outcome was CVD (atherosclerotic CVD [ASCVD] and heart failure [HF]). Predictors included traditional risk factors (smoking status, systolic blood pressure, cholesterol, anti-hypertensive or statin use, diabetes) and estimated glomerular filtration rate [eGFR]. Models were sex-specific, race-free, developed on the age-scale, and adjusted for competing risk of non-CVD death. Analyses were conducted in each dataset and meta-analyzed. Discrimination was assessed using Harrell's C-statistic. Calibration was calculated as the slope of the observed vs. predicted risk by decile. Additional equations to predict each CVD subtype (ASCVD, HF) and include optional predictors (urine albumin-to-creatinine ratio [UACR], hemoglobin A1c [HbA1c]), and social deprivation index [SDI]) were also developed. External validation was performed in 3,330,085 participants from 21 additional datasets. <b>Results:</b> Among 6,612,004 adults included, mean (SD) age was 53 (12) years and 56% were female. Over a mean (SD) follow-up of 4.8 (3.1) years, there were 211,515 incident total CVD events. The median C-statistics in external validation for CVD were 0.794 (interquartile interval [IQI]: 0.763-0.809) in female and 0.757 (0.727-0.778) in male participants. The calibration slopes were 1.03 (IQI 0.81 -1.16) and 0.94 (0.81-1.13) among females and males, respectively. Similar estimates for discrimination and calibration were observed for ASCVD- and HF-specific models. The improvement in discrimination was small but statistically significant when UACR, HbA1c, and SDI were added together to the base model to total CVD (ΔC-statistic [IQI] 0.004 [0.004, 0.005] and 0.005 [0.004, 0.007] among females and males, respectively). Calibration improved significantly when UACR was added to the base model among those with marked albuminuria (>;300mg/g) (1.05 [0.84-1.20] vs. 1.39 [1.14-1.65], p=0.01). <b>Conclusions:</b> PREVENT equations accurately and precisely predicted risk for incident CVD and CVD subtypes in a large, diverse, and contemporary sample of US adults using routinely available clinical variables.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37947085/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37947085</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067626>10.1161/CIRCULATIONAHA.123.067626</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37947085</guid>
<pubDate>Fri, 10 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Sadiya S Khan</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Yingying Sang</dc:creator>
<dc:creator>Shoshana H Ballew</dc:creator>
<dc:creator>Morgan E Grams</dc:creator>
<dc:creator>Aditya Surapaneni</dc:creator>
<dc:creator>Michael J Blaha</dc:creator>
<dc:creator>April P Carson</dc:creator>
<dc:creator>Alexander R Chang</dc:creator>
<dc:creator>Elizabeth Ciemins</dc:creator>
<dc:creator>Alan S Go</dc:creator>
<dc:creator>Orlando M Gutierrez</dc:creator>
<dc:creator>Shih-Jen Hwang</dc:creator>
<dc:creator>Simerjot K Jassal</dc:creator>
<dc:creator>Csaba P Kovesdy</dc:creator>
<dc:creator>Donald M Lloyd-Jones</dc:creator>
<dc:creator>Michael G Shlipak</dc:creator>
<dc:creator>Latha P Palaniappan</dc:creator>
<dc:creator>Laurence Sperling</dc:creator>
<dc:creator>Salim S Virani</dc:creator>
<dc:creator>Katherine Tuttle</dc:creator>
<dc:creator>Ian J Neeland</dc:creator>
<dc:creator>Sheryl L Chow</dc:creator>
<dc:creator>Janani Rangaswami</dc:creator>
<dc:creator>Michael J Pencina</dc:creator>
<dc:creator>Chiadi E Ndumele</dc:creator>
<dc:creator>Josef Coresh</dc:creator>
<dc:creator>Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group</dc:creator>
<dc:date>2023-11-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations</dc:title>
<dc:identifier>pmid:37947085</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067626</dc:identifier>
</item>
<item>
<title>RNA polymerase II dynamics and mRNA stability feedback scale mRNA amounts with cell size</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944513/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>A fundamental feature of cellular growth is that total protein and RNA amounts increase with cell size to keep concentrations approximately constant. A key component of this is that global transcription rates increase in larger cells. Here, we identify RNA polymerase II (RNAPII) as the limiting factor scaling mRNA transcription with cell size in budding yeast, as transcription is highly sensitive to the dosage of RNAPII but not to other components of the transcriptional machinery. Our...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 1:S0092-8674(23)01128-5. doi: 10.1016/j.cell.2023.10.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A fundamental feature of cellular growth is that total protein and RNA amounts increase with cell size to keep concentrations approximately constant. A key component of this is that global transcription rates increase in larger cells. Here, we identify RNA polymerase II (RNAPII) as the limiting factor scaling mRNA transcription with cell size in budding yeast, as transcription is highly sensitive to the dosage of RNAPII but not to other components of the transcriptional machinery. Our experiments support a dynamic equilibrium model where global RNAPII transcription at a given size is set by the mass action recruitment kinetics of unengaged nucleoplasmic RNAPII to the genome. However, this only drives a sub-linear increase in transcription with size, which is then partially compensated for by a decrease in mRNA decay rates as cells enlarge. Thus, limiting RNAPII and feedback on mRNA stability work in concert to scale mRNA amounts with cell size.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944513/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944513</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.10.012>10.1016/j.cell.2023.10.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944513</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Matthew P Swaffer</dc:creator>
<dc:creator>Georgi K Marinov</dc:creator>
<dc:creator>Huan Zheng</dc:creator>
<dc:creator>Lucas Fuentes Valenzuela</dc:creator>
<dc:creator>Crystal Yee Tsui</dc:creator>
<dc:creator>Andrew W Jones</dc:creator>
<dc:creator>Jessica Greenwood</dc:creator>
<dc:creator>Anshul Kundaje</dc:creator>
<dc:creator>William J Greenleaf</dc:creator>
<dc:creator>Rodrigo Reyes-Lamothe</dc:creator>
<dc:creator>Jan M Skotheim</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>RNA polymerase II dynamics and mRNA stability feedback scale mRNA amounts with cell size</dc:title>
<dc:identifier>pmid:37944513</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.10.012</dc:identifier>
</item>
<item>
<title>Design, construction, and functional characterization of a tRNA neochromosome in yeast</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944512/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>Here, we report the design, construction, and characterization of a tRNA neochromosome, a designer chromosome that functions as an additional, de novo counterpart to the native complement of Saccharomyces cerevisiae. Intending to address one of the central design principles of the Sc2.0 project, the ∼190-kb tRNA neochromosome houses all 275 relocated nuclear tRNA genes. To maximize stability, the design incorporates orthogonal genetic elements from non-S. cerevisiae yeast species. Furthermore,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 5:S0092-8674(23)01130-3. doi: 10.1016/j.cell.2023.10.015. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Here, we report the design, construction, and characterization of a tRNA neochromosome, a designer chromosome that functions as an additional, de novo counterpart to the native complement of Saccharomyces cerevisiae. Intending to address one of the central design principles of the Sc2.0 project, the ∼190-kb tRNA neochromosome houses all 275 relocated nuclear tRNA genes. To maximize stability, the design incorporates orthogonal genetic elements from non-S. cerevisiae yeast species. Furthermore, the presence of 283 rox recombination sites enables an orthogonal tRNA SCRaMbLE system. Following construction in yeast, we obtained evidence of a potent selective force, manifesting as a spontaneous doubling in cell ploidy. Furthermore, tRNA sequencing, transcriptomics, proteomics, nucleosome mapping, replication profiling, FISH, and Hi-C were undertaken to investigate questions of tRNA neochromosome behavior and function. Its construction demonstrates the remarkable tractability of the yeast model and opens up opportunities to directly test hypotheses surrounding these essential non-coding RNAs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944512/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944512</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.10.015>10.1016/j.cell.2023.10.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944512</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Daniel Schindler</dc:creator>
<dc:creator>Roy S K Walker</dc:creator>
<dc:creator>Shuangying Jiang</dc:creator>
<dc:creator>Aaron N Brooks</dc:creator>
<dc:creator>Yun Wang</dc:creator>
<dc:creator>Carolin A Müller</dc:creator>
<dc:creator>Charlotte Cockram</dc:creator>
<dc:creator>Yisha Luo</dc:creator>
<dc:creator>Alicia García</dc:creator>
<dc:creator>Daniel Schraivogel</dc:creator>
<dc:creator>Julien Mozziconacci</dc:creator>
<dc:creator>Noah Pena</dc:creator>
<dc:creator>Mahdi Assari</dc:creator>
<dc:creator>María Del Carmen Sánchez Olmos</dc:creator>
<dc:creator>Yu Zhao</dc:creator>
<dc:creator>Alba Ballerini</dc:creator>
<dc:creator>Benjamin A Blount</dc:creator>
<dc:creator>Jitong Cai</dc:creator>
<dc:creator>Lois Ogunlana</dc:creator>
<dc:creator>Wei Liu</dc:creator>
<dc:creator>Katarina Jönsson</dc:creator>
<dc:creator>Dariusz Abramczyk</dc:creator>
<dc:creator>Eva Garcia-Ruiz</dc:creator>
<dc:creator>Tomasz W Turowski</dc:creator>
<dc:creator>Reem Swidah</dc:creator>
<dc:creator>Tom Ellis</dc:creator>
<dc:creator>Tao Pan</dc:creator>
<dc:creator>Francisco Antequera</dc:creator>
<dc:creator>Yue Shen</dc:creator>
<dc:creator>Conrad A Nieduszynski</dc:creator>
<dc:creator>Romain Koszul</dc:creator>
<dc:creator>Junbiao Dai</dc:creator>
<dc:creator>Lars M Steinmetz</dc:creator>
<dc:creator>Jef D Boeke</dc:creator>
<dc:creator>Yizhi Cai</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Design, construction, and functional characterization of a tRNA neochromosome in yeast</dc:title>
<dc:identifier>pmid:37944512</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.10.015</dc:identifier>
</item>
<item>
<title>Debugging and consolidating multiple synthetic chromosomes reveals combinatorial genetic interactions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944511/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>The Sc2.0 project is building a eukaryotic synthetic genome from scratch. A major milestone has been achieved with all individual Sc2.0 chromosomes assembled. Here, we describe the consolidation of multiple synthetic chromosomes using advanced endoreduplication intercrossing with tRNA expression cassettes to generate a strain with 6.5 synthetic chromosomes. The 3D chromosome organization and transcript isoform profiles were evaluated using Hi-C and long-read direct RNA sequencing. We developed...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Oct 20:S0092-8674(23)01079-6. doi: 10.1016/j.cell.2023.09.025. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Sc2.0 project is building a eukaryotic synthetic genome from scratch. A major milestone has been achieved with all individual Sc2.0 chromosomes assembled. Here, we describe the consolidation of multiple synthetic chromosomes using advanced endoreduplication intercrossing with tRNA expression cassettes to generate a strain with 6.5 synthetic chromosomes. The 3D chromosome organization and transcript isoform profiles were evaluated using Hi-C and long-read direct RNA sequencing. We developed CRISPR Directed Biallelic URA3-assisted Genome Scan, or "CRISPR D-BUGS," to map phenotypic variants caused by specific designer modifications, known as "bugs." We first fine-mapped a bug in synthetic chromosome II (synII) and then discovered a combinatorial interaction associated with synIII and synX, revealing an unexpected genetic interaction that links transcriptional regulation, inositol metabolism, and tRNA<sub>Ser</sub><sup>CGA</sup> abundance. Finally, to expedite consolidation, we employed chromosome substitution to incorporate the largest chromosome (synIV), thereby consolidating >;50% of the Sc2.0 genome in one strain.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944511/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944511</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.09.025>10.1016/j.cell.2023.09.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944511</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Yu Zhao</dc:creator>
<dc:creator>Camila Coelho</dc:creator>
<dc:creator>Amanda L Hughes</dc:creator>
<dc:creator>Luciana Lazar-Stefanita</dc:creator>
<dc:creator>Sandy Yang</dc:creator>
<dc:creator>Aaron N Brooks</dc:creator>
<dc:creator>Roy S K Walker</dc:creator>
<dc:creator>Weimin Zhang</dc:creator>
<dc:creator>Stephanie Lauer</dc:creator>
<dc:creator>Cindy Hernandez</dc:creator>
<dc:creator>Jitong Cai</dc:creator>
<dc:creator>Leslie A Mitchell</dc:creator>
<dc:creator>Neta Agmon</dc:creator>
<dc:creator>Yue Shen</dc:creator>
<dc:creator>Joseph Sall</dc:creator>
<dc:creator>Viola Fanfani</dc:creator>
<dc:creator>Anavi Jalan</dc:creator>
<dc:creator>Jordan Rivera</dc:creator>
<dc:creator>Feng-Xia Liang</dc:creator>
<dc:creator>Joel S Bader</dc:creator>
<dc:creator>Giovanni Stracquadanio</dc:creator>
<dc:creator>Lars M Steinmetz</dc:creator>
<dc:creator>Yizhi Cai</dc:creator>
<dc:creator>Jef D Boeke</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Debugging and consolidating multiple synthetic chromosomes reveals combinatorial genetic interactions</dc:title>
<dc:identifier>pmid:37944511</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.09.025</dc:identifier>
</item>
<item>
<title>Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944164/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad672. doi: 10.1093/eurheartj/ehad672. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944164/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944164</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad672>10.1093/eurheartj/ehad672</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944164</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Nazzareno Galiè</dc:creator>
<dc:creator>Massimiliano Palazzini</dc:creator>
<dc:creator>Alessandra Manes</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds</dc:title>
<dc:identifier>pmid:37944164</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad672</dc:identifier>
</item>
<item>
<title>Correction to: Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944137/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad714. doi: 10.1093/eurheartj/ehad714. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944137/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944137</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad714>10.1093/eurheartj/ehad714</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944137</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?</dc:title>
<dc:identifier>pmid:37944137</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad714</dc:identifier>
</item>
<item>
<title>4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944136/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: 4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad662. doi: 10.1093/eurheartj/ehad662. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Developing novel therapies to battle the global public health burden of heart failure remains challenging. This study investigates the underlying mechanisms and potential treatment for 4-hydroxynonenal (4-HNE) deleterious effects in heart failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Biochemical, functional, and histochemical measurements were applied to identify 4-HNE adducts in rat and human failing hearts. In vitro studies were performed to validate 4-HNE targets.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: 4-HNE, a reactive aldehyde by-product of mitochondrial dysfunction in heart failure, covalently inhibits Dicer, an RNase III endonuclease essential for microRNA (miRNA) biogenesis. 4-HNE inhibition of Dicer impairs miRNA processing. Mechanistically, 4-HNE binds to recombinant human Dicer through an intermolecular interaction that disrupts both activity and stability of Dicer in a concentration- and time-dependent manner. Dithiothreitol neutralization of 4-HNE or replacing 4-HNE-targeted residues in Dicer prevents 4-HNE inhibition of Dicer in vitro. Interestingly, end-stage human failing hearts from three different heart failure aetiologies display defective 4-HNE clearance, decreased Dicer activity, and miRNA biogenesis impairment. Notably, boosting 4-HNE clearance through pharmacological re-activation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) using Alda-1 or its improved orally bioavailable derivative AD-9308 restores Dicer activity. ALDH2 is a major enzyme responsible for 4-HNE removal. Importantly, this response is accompanied by improved miRNA maturation and cardiac function/remodelling in a pre-clinical model of heart failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: 4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944136/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944136</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad662>10.1093/eurheartj/ehad662</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944136</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Ligia A Kiyuna</dc:creator>
<dc:creator>Darlan S Candido</dc:creator>
<dc:creator>Luiz R G Bechara</dc:creator>
<dc:creator>Itamar C G Jesus</dc:creator>
<dc:creator>Lisley S Ramalho</dc:creator>
<dc:creator>Barbara Krum</dc:creator>
<dc:creator>Ruda P Albuquerque</dc:creator>
<dc:creator>Juliane C Campos</dc:creator>
<dc:creator>Luiz H M Bozi</dc:creator>
<dc:creator>Vanessa O Zambelli</dc:creator>
<dc:creator>Ariane N Alves</dc:creator>
<dc:creator>Nicolás Campolo</dc:creator>
<dc:creator>Mauricio Mastrogiovanni</dc:creator>
<dc:creator>Silvina Bartesaghi</dc:creator>
<dc:creator>Alejandro Leyva</dc:creator>
<dc:creator>Rosario Durán</dc:creator>
<dc:creator>Rafael Radi</dc:creator>
<dc:creator>Guilherme M Arantes</dc:creator>
<dc:creator>Edécio Cunha-Neto</dc:creator>
<dc:creator>Marcelo A Mori</dc:creator>
<dc:creator>Che-Hong Chen</dc:creator>
<dc:creator>Wenjin Yang</dc:creator>
<dc:creator>Daria Mochly-Rosen</dc:creator>
<dc:creator>Ian J MacRae</dc:creator>
<dc:creator>Ludmila R P Ferreira</dc:creator>
<dc:creator>Julio C B Ferreira</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification</dc:title>
<dc:identifier>pmid:37944136</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad662</dc:identifier>
</item>
<item>
<title>Game changer epidemiological studies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944059/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7;44(42):4393-4397. doi: 10.1093/eurheartj/ehad739.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944059/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944059</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad739>10.1093/eurheartj/ehad739</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944059</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Game changer epidemiological studies</dc:title>
<dc:identifier>pmid:37944059</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad739</dc:identifier>
</item>
<item>
<title>Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944038/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad489. doi: 10.1093/eurheartj/ehad489. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944038/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944038</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad489>10.1093/eurheartj/ehad489</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944038</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Heinz-Peter Schultheiss</dc:creator>
<dc:creator>Felicitas Escher</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome</dc:title>
<dc:identifier>pmid:37944038</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad489</dc:identifier>
</item>
<item>
<title>The European Society of Cardiology working group on atherosclerosis and vascular biology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad536. doi: 10.1093/eurheartj/ehad536. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944036</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad536>10.1093/eurheartj/ehad536</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944036</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Esther Lutgens</dc:creator>
<dc:creator>Elena Osto</dc:creator>
<dc:creator>Marie-Luce Bochaton-Piallat</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The European Society of Cardiology working group on atherosclerosis and vascular biology</dc:title>
<dc:identifier>pmid:37944036</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad536</dc:identifier>
</item>
<item>
<title>Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37944029/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 7:ehad665. doi: 10.1093/eurheartj/ehad665. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37944029/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37944029</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad665>10.1093/eurheartj/ehad665</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37944029</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Wai Hong Wilson Tang</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges</dc:title>
<dc:identifier>pmid:37944029</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad665</dc:identifier>
</item>
<item>
<title>New Way to Study Pulmonary Hypertension in HFpEF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):899-901. doi: 10.1161/CIRCRESAHA.123.323753. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37943948</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323753>10.1161/CIRCRESAHA.123.323753</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943948</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:creator>Edward Benjamin Thorp</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>New Way to Study Pulmonary Hypertension in HFpEF</dc:title>
<dc:identifier>pmid:37943948</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323753</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943946/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):884. doi: 10.1161/RES.0000000000000643. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943946/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37943946</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000643>10.1161/RES.0000000000000643</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943946</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37943946</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000643</dc:identifier>
</item>
<item>
<title>Receptor-Specific Inside-Out cAMP Signaling Regulates Cardiomyocyte Fate</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37943945/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Nov 10;133(11):924-926. doi: 10.1161/CIRCRESAHA.123.323754. Epub 2023 Nov 9.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37943945/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37943945</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323754>10.1161/CIRCRESAHA.123.323754</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37943945</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Frank Lezoualc'h</dc:creator>
<dc:creator>Viacheslav O Nikolaev</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Receptor-Specific Inside-Out cAMP Signaling Regulates Cardiomyocyte Fate</dc:title>
<dc:identifier>pmid:37943945</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323754</dc:identifier>
</item>
<item>
<title>2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37942682/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231110193728&amp;v=2.17.9.post6+86293ac
      <description>The International Liaison Committee on Resuscitation engages in a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation and first aid science. Draft Consensus on Science With Treatment Recommendations are posted online throughout the year, and this annual summary provides more concise versions of the final Consensus on Science With Treatment Recommendations from all task forces for the year. Topics addressed by systematic reviews this year include resuscitation of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Nov 9. doi: 10.1161/CIR.0000000000001179. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The International Liaison Committee on Resuscitation engages in a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation and first aid science. Draft Consensus on Science With Treatment Recommendations are posted online throughout the year, and this annual summary provides more concise versions of the final Consensus on Science With Treatment Recommendations from all task forces for the year. Topics addressed by systematic reviews this year include resuscitation of cardiac arrest from drowning, extracorporeal cardiopulmonary resuscitation for adults and children, calcium during cardiac arrest, double sequential defibrillation, neuroprognostication after cardiac arrest for adults and children, maintaining normal temperature after preterm birth, heart rate monitoring methods for diagnostics in neonates, detection of exhaled carbon dioxide in neonates, family presence during resuscitation of adults, and a stepwise approach to resuscitation skills training. Members from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the quality of the evidence, using Grading of Recommendations Assessment, Development, and Evaluation criteria, and their statements include consensus treatment recommendations. Insights into the deliberations of the task forces are provided in the Justification and Evidence-to-Decision Framework Highlights sections. In addition, the task forces list priority knowledge gaps for further research. Additional topics are addressed with scoping reviews and evidence updates.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37942682/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231110193728&v=2.17.9.post6+86293ac">37942682</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001179>10.1161/CIR.0000000000001179</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37942682</guid>
<pubDate>Thu, 09 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Katherine M Berg</dc:creator>
<dc:creator>Janet E Bray</dc:creator>
<dc:creator>Kee-Chong Ng</dc:creator>
<dc:creator>Helen G Liley</dc:creator>
<dc:creator>Robert Greif</dc:creator>
<dc:creator>Jestin N Carlson</dc:creator>
<dc:creator>Peter T Morley</dc:creator>
<dc:creator>Ian R Drennan</dc:creator>
<dc:creator>Michael Smyth</dc:creator>
<dc:creator>Barnaby R Scholefield</dc:creator>
<dc:creator>Gary M Weiner</dc:creator>
<dc:creator>Adam Cheng</dc:creator>
<dc:creator>Therese Djärv</dc:creator>
<dc:creator>Cristian Abelairas-Gómez</dc:creator>
<dc:creator>Jason Acworth</dc:creator>
<dc:creator>Lars W Andersen</dc:creator>
<dc:creator>Dianne L Atkins</dc:creator>
<dc:creator>David C Berry</dc:creator>
<dc:creator>Farhan Bhanji</dc:creator>
<dc:creator>Joost Bierens</dc:creator>
<dc:creator>Thomaz Bittencourt Couto</dc:creator>
<dc:creator>Vere Borra</dc:creator>
<dc:creator>Bernd W Böttiger</dc:creator>
<dc:creator>Richard N Bradley</dc:creator>
<dc:creator>Jan Breckwoldt</dc:creator>
<dc:creator>Pascal Cassan</dc:creator>
<dc:creator>Wei-Tien Chang</dc:creator>
<dc:creator>Nathan P Charlton</dc:creator>
<dc:creator>Sung Phil Chung</dc:creator>
<dc:creator>Julie Considine</dc:creator>
<dc:creator>Daniela T Costa-Nobre</dc:creator>
<dc:creator>Keith Couper</dc:creator>
<dc:creator>Katie N Dainty</dc:creator>
<dc:creator>Vihara Dassanayake</dc:creator>
<dc:creator>Peter G Davis</dc:creator>
<dc:creator>Jennifer A Dawson</dc:creator>
<dc:creator>Maria Fernanda de Almeida</dc:creator>
<dc:creator>Allan R De Caen</dc:creator>
<dc:creator>Charles D Deakin</dc:creator>
<dc:creator>Bridget Dicker</dc:creator>
<dc:creator>Matthew J Douma</dc:creator>
<dc:creator>Kathryn Eastwood</dc:creator>
<dc:creator>Walid El-Naggar</dc:creator>
<dc:creator>Jorge G Fabres</dc:creator>
<dc:creator>Joe Fawke</dc:creator>
<dc:creator>Nino Fijacko</dc:creator>
<dc:creator>Judith C Finn</dc:creator>
<dc:creator>Gustavo E Flores</dc:creator>
<dc:creator>Elizabeth E Foglia</dc:creator>
<dc:creator>Fredrik Folke</dc:creator>
<dc:creator>Elaine Gilfoyle</dc:creator>
<dc:creator>Craig A Goolsby</dc:creator>
<dc:creator>Asger Granfeldt</dc:creator>
<dc:creator>Anne-Marie Guerguerian</dc:creator>
<dc:creator>Ruth Guinsburg</dc:creator>
<dc:creator>Tetsuo Hatanaka</dc:creator>
<dc:creator>Karen G Hirsch</dc:creator>
<dc:creator>Mathias J Holmberg</dc:creator>
<dc:creator>Shigeharu Hosono</dc:creator>
<dc:creator>Ming-Ju Hsieh</dc:creator>
<dc:creator>Cindy H Hsu</dc:creator>
<dc:creator>Takanari Ikeyama</dc:creator>
<dc:creator>Tetsuya Isayama</dc:creator>
<dc:creator>Nicholas J Johnson</dc:creator>
<dc:creator>Vishal S Kapadia</dc:creator>
<dc:creator>Mandira Daripa Kawakami</dc:creator>
<dc:creator>Han-Suk Kim</dc:creator>
<dc:creator>Monica E Kleinman</dc:creator>
<dc:creator>David A Kloeck</dc:creator>
<dc:creator>Peter Kudenchuk</dc:creator>
<dc:creator>Amy Kule</dc:creator>
<dc:creator>Hiroshi Kurosawa</dc:creator>
<dc:creator>Anthony T Lagina</dc:creator>
<dc:creator>Kasper G Lauridsen</dc:creator>
<dc:creator>Eric J Lavonas</dc:creator>
<dc:creator>Henry C Lee</dc:creator>
<dc:creator>Yiqun Lin</dc:creator>
<dc:creator>Andrew S Lockey</dc:creator>
<dc:creator>Finlay Macneil</dc:creator>
<dc:creator>Ian K Maconochie</dc:creator>
<dc:creator>R John Madar</dc:creator>
<dc:creator>Carolina Malta Hansen</dc:creator>
<dc:creator>Siobhan Masterson</dc:creator>
<dc:creator>Tasuku Matsuyama</dc:creator>
<dc:creator>Christopher J D McKinlay</dc:creator>
<dc:creator>Daniel Meyran</dc:creator>
<dc:creator>Vix Monnelly</dc:creator>
<dc:creator>Vinay Nadkarni</dc:creator>
<dc:creator>Firdose L Nakwa</dc:creator>
<dc:creator>Kevin J Nation</dc:creator>
<dc:creator>Ziad Nehme</dc:creator>
<dc:creator>Michael Nemeth</dc:creator>
<dc:creator>Robert W Neumar</dc:creator>
<dc:creator>Tonia Nicholson</dc:creator>
<dc:creator>Nikolaos Nikolaou</dc:creator>
<dc:creator>Chika Nishiyama</dc:creator>
<dc:creator>Tatsuya Norii</dc:creator>
<dc:creator>Gabrielle A Nuthall</dc:creator>
<dc:creator>Shinchiro Ohshimo</dc:creator>
<dc:creator>Theresa M Olasveengen</dc:creator>
<dc:creator>Yong-Kwang Gene Ong</dc:creator>
<dc:creator>Aaron M Orkin</dc:creator>
<dc:creator>Michael J Parr</dc:creator>
<dc:creator>Catherine Patocka</dc:creator>
<dc:creator>Gavin D Perkins</dc:creator>
<dc:creator>Jeffrey M Perlman</dc:creator>
<dc:creator>Yacov Rabi</dc:creator>
<dc:creator>James Raitt</dc:creator>
<dc:creator>Shalini Ramachandran</dc:creator>
<dc:creator>Viraraghavan V Ramaswamy</dc:creator>
<dc:creator>Tia T Raymond</dc:creator>
<dc:creator>Amelia G Reis</dc:creator>
<dc:creator>Joshua C Reynolds</dc:creator>
<dc:creator>Giuseppe Ristagno</dc:creator>
<dc:creator>Antonio Rodriguez-Nunez</dc:creator>
<dc:creator>Charles C Roehr</dc:creator>
<dc:creator>Mario Rüdiger</dc:creator>
<dc:creator>Tetsuya Sakamoto</dc:creator>
<dc:creator>Claudio Sandroni</dc:creator>
<dc:creator>Taylor L Sawyer</dc:creator>
<dc:creator>Steve M Schexnayder</dc:creator>
<dc:creator>Georg M Schmölzer</dc:creator>
<dc:creator>Sebastian Schnaubelt</dc:creator>
<dc:creator>Federico Semeraro</dc:creator>
<dc:creator>Eunice M Singletary</dc:creator>
<dc:creator>Markus B Skrifvars</dc:creator>
<dc:creator>Christopher M Smith</dc:creator>
<dc:creator>Jasmeet Soar</dc:creator>
<dc:creator>Willem Stassen</dc:creator>
<dc:creator>Takahiro Sugiura</dc:creator>
<dc:creator>Janice A Tijssen</dc:creator>
<dc:creator>Alexis A Topjian</dc:creator>
<dc:creator>Daniele Trevisanuto</dc:creator>
<dc:creator>Christian Vaillancourt</dc:creator>
<dc:creator>Myra H Wyckoff</dc:creator>
<dc:creator>Jonathan P Wyllie</dc:creator>
<dc:creator>Chih-Wei Yang</dc:creator>
<dc:creator>Joyce Yeung</dc:creator>
<dc:creator>Carolyn M Zelop</dc:creator>
<dc:creator>David A Zideman</dc:creator>
<dc:creator>Jerry P Nolan</dc:creator>
<dc:creator>Collaborators</dc:creator>
<dc:date>2023-11-09</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</dc:title>
<dc:identifier>pmid:37942682</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001179</dc:identifier>
</item>





























</channel>
</rss>